cagri and tirzepatide together Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes Buy Cagrilintide (CAGRI) 5mg —

for long-term metabolic outcomes Biohacker Microdosing Dose: 0.5 1 mg every 3 days (variant 5 mg pen = 1530 clicks / variant 10 mg pen = 510 clicks / variant 15 mg pen = 510 clicks) Duration: 4 8 weeks Frequency: Every 3 days Cycle Interval: Repeat after 1 month Goal / Description: Used experimentally to assess mild appetite control and metabolic priming Maintenance Phase Dose: 2.5 5 mg (variant 5 mg pen = 76152 clicks / variant 10 mg pen = 2550 clicks / variant 15 mg pen = 2550 clicks) Duration: Variable Frequency: 1 weekly Cycle Interval: Continuous Goal / Description: Sustain achieved body composition and metabolic balance

According to the Ozempic Summary of Product Characteristics (SmPC), injection site reactions are classified as 'uncommon', meaning they affect between 1 in 100 and 1 in 1,000 patients (trial rates were typically below 1%)

Keep your medication organized, especially if you receive multiple vials at once

Many people find that after 3 to 4 weeks of consistent dietary changes and bioavailable supplementation, they feel a noticeable difference in their daily energy and overall resilience.

See the full release here